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Abstract
The first positive genome-wide association study on gestational length and preterm delivery showed the involvement of an Semetabolism gene.
In the present study, we examine the association between maternal intake of Se and Se status with gestational length and preterm delivery in
72 025 women with singleton live births from the population-based, prospective Norwegian Mother, Father and Child Cohort Study (MoBa). A
self-reported, semi-quantitative FFQ answered in pregnancy week 22 was used to estimate Se intake during the first half of pregnancy.
Associations were analysed with adjusted linear and Cox regressions. Se status was assessed in whole blood collected in gestational week 17
(n 2637). Median dietary Se intake was 53 (interquartile range (IQR) 44–62) μg/d, supplements provided additionally 50 (IQR 30–75) μg/d for
supplement users (n 23 409). Maternal dietary Se intake was significantly associated with prolonged gestational length (β per SD= 0·25, 95 % CI,
0·07, 0·43) and decreased risk of preterm delivery (n 3618, hazard ratio per SD= 0·92, 95%CI, 0·87, 0·98). Neither Se intake from supplements nor
maternal blood Se status was associated with gestational length or preterm delivery. Hence, the present study showed that maternal dietary Se
intake but not intake of Se-containing supplements, during the first half of pregnancy was significantly associated with decreased risk of preterm
delivery. Further investigations, preferably in the form of a large randomised controlled trial, are needed to elucidate the impact of Se on preg-
nancy duration.
Key words: Preterm delivery: Gestational length: Selenium: Norwegian Mother, Father and Child Cohort Study: MoBa: Dietary
selenium intake: Selenium status
Preterm delivery (PTD; delivery before completing 37 weeks
of gestation) affects 5–13 % of all pregnancies worldwide,
though the incidence varies a lot even between high-income
countries(1–3). It is the leading cause of neonatal morbidity and
mortality. There is nowayof predicting orpreventing spontaneous
PTD, but it is urgent to identify modifiable factors influencing the
Abbreviations: EEFSEC, eukaryotic elongation factor, selenocysteine transfer RNA specific; HR, hazard ratio; IQR, interquartile range; MBRN, Medical Birth
Registry of Norway; MoBa, Norwegian Mother, Father and Child Cohort Study; PTD, preterm delivery; RDI, recommended daily intake.
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prevalence of PTD and to understand the pathways that regulate
the timing of birth.
Our research group recently performed a genome-wide
association study regarding gestational length and PTD in a
discovery cohort of 43 568 women of European ancestry(4).
Four loci achieved genome-wide significance: the eukaryotic
elongation factor, selenocysteine transfer RNA-specific (EEFSEC)
gene was significant for both gestational length and risk of PTD.
These associations were confirmed in three Nordic cohorts,
among others the Norwegian Mother and Child Cohort
Study (MoBa).
The EEFSEC gene codes for the protein EEFSEC, which is
an elongation factor necessary for the co-translational incorpora-
tion of Se into the amino acid selenocysteine and thus selenopro-
teins. Se is an essential trace element. Its biological function
is transferred via some twenty-five selenoproteins, and Se depri-
vation limits the syntheses of these proteins. Selenoproteins, such
as the glutathione peroxidases and the thioredoxin reductases,
have important cellular homeostatic functions in maintaining
redox status and antioxidant defence as well as in modulating
inflammatory responses(5). The Se-containing 5’deiodinases,
which are required for thyroid hormone activity, are impor-
tant in the regulation of growth and energy metabolism(6).
Redox status, inflammation and regulation of energy metabo-
lism have been linked to the parturition process and risk of
PTD(7–10). The identification of the selenocysteine pathway
in PTD suggests that maternal Se status may be important.
The fact that Se deficiency is prevalent in Malawi, the country
with the highest frequency of PTD(11,12), further supports the
hypothesis. The few existing studies on Se metabolism with
regard to gestational length present contradicting results.
Data from the National Birth Defects Prevention Study on
5738 deliveries (471 PTD cases) found no relationship
between Se intake before pregnancy, measured in retrospect,
and the risk of PTD (13). Similarly, a small observational study
(n 233) in the USA found no association between Se concen-
tration in plasma and PTD(14). However, the study found that
women delivering preterm (n 107) had higher estimated Se
intake during early pregnancy compared with women
delivering at term (n 126)(14). A third observational study
found that women who delivered preterm (n 60) on the
contrary had lower serum Se concentration at gestational
week 12 compared with those who delivered at term
(n 1069)(15).
The aim of the present study is to examine the association
between self-reported maternal dietary intake of Se during the
first half of pregnancy and maternal Se status as indicated by
the whole-blood concentration of Se at week 17 and two




The present study is based on MoBa, an ongoing prospective
population-based pregnancy cohort administered by the
Norwegian Institute of Public Health(16). Participants were
recruited from all over Norway from 1999 to 2008, with a
participation rate of 41 %. The cohort now includes 114 500
children, 95 200 mothers and 75 200 fathers(16).
Pregnant women were invited by postal invitation in connec-
tion with the routine ultrasound screening offered free of charge
to all women in gestational weeks 17–19. They were asked to
answer three questionnaires during their pregnancies and to
donate blood and urine samples at the time of ultrasound screen-
ing. Participants were followed up regularly with questionnaires
after delivery. The present study is based on information from
the first questionnaire (Q1) about general health status and
lifestyle, which was filled out around gestational weeks 15–17,
and the semi-quantitative FFQ filled out around gestational
week 22. Pregnancy and birth records from the Medical Birth
Registry of Norway (MBRN) were linked to the MoBa
database(16). MBRN is a national health registry containing
information about all births in Norway. The present study is
based on version 8 of the quality-assured data files released
for research in 2014. Only women with singleton live births
after gestational week 22þ0 and women with valid estimates
of total energy intake (between 4·5 and 20 MJ) were included.
Women who participated in the cohort with more than one
pregnancy were included only with their first enrolled preg-
nancy. Fig. 1 outlines the selection of the study population.
Fig. 1. Flow chart over the study population. * The present FFQ was not used
before 2002, explaining the drop of numbers from boxes 3 to 4. † Selenium
was measured in n 2982 women. MoBa, Norwegian Mother, Father and Child
Cohort Study.
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Selenium intake
Intake of Se (μg/d) from food and dietary supplements was esti-
mated based on self-reported food and supplement intake in the
MoBa (FFQ). The MoBa FFQ is a semi-quantitative instrument
designed to record dietary habits and intakes of dietary supple-
ments during the first 4–5 months of pregnancy, that is, from the
start of pregnancy until around gestational week 22(17). The FFQ
includes questions about the intake of 255 food items or dishes.
The FFQ has been validated in an MoBa subpopulation (n 119)
using a 4-d weighed food diary and biological markers in blood
and urine as reference measures(18,19), showing that the MoBa
FFQ is a valid tool for assessing dietary intake of energy,
nutrients and food in the first 4–5 months of pregnancy.
The present version of the FFQ was used from March 2002
throughout the recruitment period. Completed questionnaires
were optically read, and the consumption frequencies were con-
verted into food amounts (g/d) using standard Norwegian por-
tion sizes(17). Intake of Se and other nutrients from food was
based on FoodCalc(20) and the Norwegian food composition
table(21). Se occurring naturally in foods is thought to be mostly
selenomethionine.
Theparticipantswere asked to report the use of dietary supple-
ments by writing name and brand as well as the frequency and
amount. To calculate nutrient intake from supplements, a data-
base of more than 1000 dietary supplements was created based
on the producers’ declared nutrient content information(22,23).
Available Se supplements contained one or more forms of
Se, including inorganic selenite or selenate, selenomethionine,
Se-methylselenocysteine or selenised yeast(24). These forms differ
in their impact on tissue Se concentration(25). The supplementary
Se intakewas estimated and analysed separately for inorganic and
organic supplements.
Selenium status
A subgroup of theMoBaparticipants (n 2999) was also included in
the Norwegian Environmental Biobank, a new project established
by the Norwegian Institute of Public Health(26,27). Inclusion
criteria for the Norwegian Environmental Biobank were available
wholeblood, urine andplasma samples, available genetic data and
available data from MoBa questionnaires 1–6 and the father
questionnaire(26,27). Whole blood was collected in heparin tubes
in gestational weeks 17–18 and shipped by ordinary mail (unrefri-
gerated) in a Vacutainer for long-term freezing at a central
bio-repository(28,29). Storage temperature for whole blood was –
20°C(27). Se analyses were conducted at Lund University,
Sweden, by inductive coupled plasma MS (iCAP Q; Thermo
Fisher Scientific, Bremen, GmbH) equipped with a collision cell
having kinetic energy discrimination and helium as collision gas.
The detection limit was 3·2 μg/l, and the CV was 1·5 %. The ana-
lytical accuracy was verified using certified reference materials,
Seronorm Trace elements whole blood L-1 and L-2 (SERO AS,
Billingstad, Norway). The results obtained were represented as
mean (standard deviation (SD)) were for L-1 (Lot 1103128,
N 205) 56·1 (5·7) μg/l v. recommended 59 (35–83) μg/l and for
L-2 (Lot 1103129, N 205) 116 (1·5) μg/l v. recommended 112
(66–158) μg/l(27). Blood Se reflects both status and uptake while
plasma/serum Se only reflects short-term status(30).
Se measurements were available for 2637 of the 72 025
women included in the present study.
Outcome variables
Gestational length in days was determined in second trimester
using ultrasound in 98·2 % of the pregnancies and based on last
menstrual period in the remaining pregnancies. PTD was
defined as birth between week 22þ0 and 36þ6. Early PTD was
defined as delivery between week 22þ0 and 33þ6, late PTD as
week 34þ0 and 36þ6, early term as 37þ0 and 38þ6 and late term
as deliveries after week 39þ0. Spontaneous PTD was defined as
birth after preterm labour or preterm pre-labour rupture of
membranes.
Covariates
All multivariate models with Se intake (from food or from supple-
ments) as exposure variable were adjusted for the following
pre-defined covariates: maternal age, parity, maternal smoking
habits during pregnancy, alcohol consumption, maternal educa-
tion, pre-pregnancy BMI, iodine intake, protein intake, fibre
intake, n-3 intake and total energy intake. Further, models were
mutually adjusted for the different Se sources (dietary intake,
organic supplements, inorganic supplements). Multivariate mod-
els with Se status as exposure variable were adjusted for maternal
age, parity, maternal smoking habits during pregnancy, alcohol
consumption, maternal education and pre-pregnancy BMI.
Information regarding maternal age at delivery was obtained
from MBRN and used as a continuous variable in the regression
models. Information on parity was based on the data from both
MBRN and the first MoBa questionnaire (Q1) that were distrib-
uted in pregnancyweek 15–17 and divided into categories based
on the number of previous pregnancies of ≥22þ0 weeks of ges-
tation: 0, 1 or >1 previous births. All other covariates were
obtained from the MoBa questionnaire Q1. Maternal education
was categorised as <13, 13–16, >16 years or missing. Smoking
during pregnancy was categorised as non-smoker, occasional
or daily smoker. Consumption of alcohol-containing beverages
was self-reported in the FFQ (glasses per d, week or month) and
dichotomised (yes or no) in the analyses. Pre-pregnancy BMI
was based on the self-reported pre-pregnancy height and
weight. BMI was grouped according to WHO classification as
underweight (<18·5 kg/m2), normal-weight (18·5–24·9 kg/m2),
overweight (25·0–29·9 kg/m2) and obese (≥30·0 kg/m2).
Dietary fibre was included as a proxy for a healthy diet. We have
previously reported that the ‘healthy/prudent dietary pattern’
correlated with fibre intake (r 0·57)(31). The study population
has been shown to be moderately iodine deficient(32,33), and
iodine has also been found to be associated with PTD(34). As
dietary iodine and Se intake correlated with r 0·57, and both
are important for thyroid hormone production, iodine intake
ranked into quintiles was included in the models. Models were
also adjusted for dietary n-3 intake since Se and n-3 are both
abundant in marine foods and n-3 intake also has been found
to decrease the risk of PTD and increase pregnancy length(35,36).
All models were adjusted for total energy intake in kilo Joules
(kJ) as well as for total protein intake since many Se sources
are protein rich such as meat, poultry and fish. All variables
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extracted from the MoBa questionnaires were used as categori-
cal variables in the regression models, with missing data as a cat-
egory of its own.
Statistical methods
All statistical analyses were performed using SPSS Statistics
version 25.0 (International Business Machines Corp., IBM). All
P values were two sided and values <0·05 were considered sig-
nificant. Spearman’s correlation test was used to evaluate the
correlation between Se intake and blood Se concentration
(Table 1). Differences in Se intake and Se status according to
maternal characteristics were studied with the Kruskal–Wallis
test (Table 2). Multiple linear regression analysis (using the
UNIANOVA command in SPSS) was used to analyse the associ-
ation between Se intake or Se status and gestational length as a
continuous variable (Tables 3 and 5). The association between
Se intake/status and PTD was estimated as a hazard ratio (HR)
with a 95 % CI using multivariable Cox regression (Tables 4
and 6). All analyses were performed with and without adjust-
ment for the confounders listed previously. A sub-analysis was
performed in order to study the association between Se intake
and different categories of PTD (early preterm, late preterm
and early term) (online Supplementary Table S1). In order to
study the possible threshold effects between Se intake and
PTD, Se intake from diet was analysed in deciles (online
Supplementary Table S2). The category closest to the recom-
mended daily intake (RDI; 60 μg/d) was used as the reference.
Regarding power, in the analysis based on dietary Se intake, the
group sizes are very large (3618 PTD v. 68 407 term deliveries)
and hence even small differences can be detected. For Se status
based on the subgroup with blood samples, the groups sizes are
smaller (80 v. 2558). Here, a difference between PTD and term
deliveries of 0·32 Cohen’s d can be detectedwith 80% power at a
significant level of 0·05.
Ethical approvals
The establishment of MoBa and initial data collection was based
on a license from the Norwegian Data protection agency and
approval from The Regional Committee for Medical Research
Ethics. The MoBa cohort is currently regulated by the
Norwegian Health Registry Act. The present studywas approved
by The Regional Committee for Medical Research Ethics (2015/
2425/Rek sør-øst A).
Results
Selenium intake and selenium status in the study
population
The median intake of Se from the diet was 53 (interquartile
range (IQR) 44–62) μg/d for all women (n 72 025, Table 1).
Fig. 2 shows how much the different food groups contributed
to dietary Se intake. Seafood, bread, meat and pasta accounted
for 24, 19, 19 and 10 % of the Se in the diet, respectively. Other
important sources included dairy products, fruits and vegeta-
bles, eggs and cheese (Fig. 2). In Norway, no food items
are fortified with Se.
Median Se intake from supplements was 50 (IQR 30–75) μg/d
for the 23 409 (33 %) Se supplement users (Table 1). Most of
these women (n 20 812) consumed Se supplements containing
only inorganic selenate or selenite, which provided a median
supplemental intake of 50 (IQR 35–75) μg/d (Table 1). A smaller
number (n 3283) took supplements containing organic seleno-
methionine or selenised yeast, which provided amedian supple-
mental intake of 30 (IQR 21–43) μg/d (Table 1). The RDI of Se
for pregnant women is 60 μg/d. About a third of the cohort
(n 21 073) met the recommended dietary intake from their diet
alone, while half (n 36 135) did so through the use of Se-
containing supplements. The women with a dietary Se intake
above RDI were those more likely to consume Se supplements
compared with women whose Se intake is below RDI
(33 v. 32 %, P= 0·005).
Median whole-blood Se concentration (Se status) was 102
(IQR 89–117) μg/l. This parameter correlated weakly with the
estimated dietary Se intake (Spearman’s ρ= 0·135, P < 0·001);
while it was not correlated with estimated Se intake from supple-
ments (Table 1). The distribution of Se intake and whole-blood
Se concentration is shown in Fig. 3.
Maternal characteristics in relation to selenium intake and
selenium status
Dietary Se intake differed by most of the maternal characteristics
studied (Table 2). Dietary Se intake was positively associated
with age, education, household income, parity, gestational
length, alcohol consumption during pregnancy, iodine intake,
protein intake, n-3 intake, fibre intake and total energy intake,
while it was negatively associated with smoking and BMI
(Table 2).
Table 1. Correlation between selenium intake and whole-blood concentration of selenium
(Numbers of subjects; medians and interquartile ranges (IQR); correlations and 95 % confidence intervals)
Se intake (μg/d)
Correlations between intake and whole-blood
concentrations
All subjects Supplement users only All subjects Supplement users only
n Median IQR n Median IQR n Rho* 95 % CI n Rho 95 % CI
Diet 72 025 53 44–62 23 409 53 44–63 2638 0·135 0·10, 0·17 914 0·115 0·05, 0·18
All supplements (organic þ inorganic) 72 025 0 0–30 23 409 50 30–75 2638 0·144 0·11, 0·18 914 −0·016 −0·05, 0·05
Organic Se supplement 72 025 0 0–0 3283 30 21–43 2357 0·080 0·04, 0·12 112 0·148 −0·04, 0·32
Inorganic Se supplement 72 025 0 0–21 20 812 50 35–75 2357 0·106 0·07, 0·15 828 −0·014 −0·08, 0·05
* Spearman correlation.
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Table 2. Maternal dietary selenium intake and maternal blood selenium concentration according to maternal characteristics†
(Numbers of subjects and percentages; medians and interquartile ranges (IQR))
Se intake from food (μg/d) Blood Se concentration (μg/l)
n % Median IQR P * n % Median IQR P *
Total 72 025 100 53 44–62 2638
Maternal age (years) <25 8284 12 50 41–62 <0·0001 220 8 98 86–112 <0·0001
25–29 24 411 34 52 43–62 947 36 102 88–116
30–34 30 524 42 53 45–63 1180 45 102 90–118
>34 8806 12 54 46–64 291 11 105 91–122
Pre-pregnancy BMI (kg/m2) <18·5 2143 53 44–64 <0·0001 81 3 104 91–116 0·024
18·5–24·9 46 163 64 53 45–63 1703 65 102 90–119
25–30 15 189 21 52 43–62 611 23 101 88–116
>30 6657 9 51 42–61 194 7 100 86–114
Missing 1873 3 53 44–62 49 2 101 93–113
Parity 0 38 310 53 52 43–62 <0·0001 1515 57 104 91–119 <0·0001
1 21 650 30 53 44–62 755 29 101 88–115
2 9700 13 54 45–63 317 12 100 87–115
3þ 2306 3 54 45–64 50 2 91 81–103
Missing 59 0 56 45–64 1 0 112 112–112
Preterm birth Yes 3618 5 52 44–62 0·022 80 3 103 90–114 0·769
No 68 407 95 53 44–62 2558 97 102 89–117
Gestational age groups Early preterm (GW 22–33) 952 1 51 43–61 0·026 8 0 92 81–102 0·434
Late preterm (GW 34–36) 2666 4 53 44–62 72 3 104 93–115
Early term (GW 37–38) 11 660 16 53 44–63 410 16 102 89–117
Late term (GW 39–42) 56 747 79 53 44–62 2148 81 102 89–117
Maternal education (years) <13 22 424 31 51 42–62 <0·0001 677 26 100 86–114 <0·0001
13–16 29 854 41 53 44–62 1248 47 101 88–116
>16 18 202 25 54 46–64 655 29 107 94–122
Missing 1545 2 51 42–62 58 2 98 87–115
Smoking habits Never 65 765 91 53 44–62 <0·0001 2462 93 102 90–118 0·001
Occasionally 1953 3 52 43–63 63 2 99 90–113
Daily 3900 5 52 42–62 103 4 95 85–110
Missing 407 1 52 43–62 10 0 97 90–114
Alcohol consumption No 64 079 89 53 44–62 <0·0001 2329 88 102 89–117 0·02
Yes 7946 11 54 46–63 309 12 104 92–120
Iodine intake (μg/d) <82 14 389 20 42 35–49 <0·0001 510 19 101 88–118 0·50
82–108 14 389 20 49 42–56 554 21 103 90–118
108–135 14 389 20 52 45–60 523 20 102 89–117
135–174 14 389 20 57 50–65 554 21 103 91–117
>174 14 389 20 65 56–75 497 19 101 88–116
n-3 intake (g/d) <0·25 26 547 37 46 38–54 <0·0001 986 37 98 87–113 <0·0001
0·25–0·47 24 548 34 53 46–61 977 37 105 91–118
>0·47 20 851 29 62 53–72 675 26 106 92–120
Protein intake (g/d) <76 24 008 33 42 36–48 <0·0001 868 33 102 88–118 0·79
76–93 24 009 33 53 47–59 907 34 102 89–117
>93 24 008 33 65 58–74 863 32 102 90–117
Fibre intake (g/d) <26 24 008 33 43 37–51 <0·0001 870 33 101 88–116 0·04
26–35 24 009 33 53 46–60 933 35 102 89–117
>35 24 008 33 63 55–72 835 32 104 90–118
Energy intake (MJ/d) <8390 24 008 33 44 37–50 <0·0001 913 35 103 90–118 0·21
8390–10 460 24 009 33 53 46–60 893 34 102 89–117
>10 460 24 008 33 63 55–73 832 32 101 89–117
GW, gestational week.
* P value obtained with the Mann–Whitney U test for two groups and the Kruskal–Wallis test for more than two groups.
† Amount of daily Se intake from food (FFQ data) and concentration of Se in blood in mid-pregnancy, according to maternal characteristics, from 72 025 participants in the Norwegian Mother and Child Cohort Study. Se intake from food was
















Se status was positively associated with age, education, alco-
hol consumption, n-3 intake and fibre intake and negatively
associated with maternal BMI, parity and smoking (Table 2).
Maternal selenium intake and gestational length
Dietary Se intake was positively associated with the length of
gestation; β per SD= 0·25, adjusted model, that is, an increase
in intake of Se by 1 SD, 14·6 μg/d, increased gestation by 6 h
(Table 3). Regression analysis for spontaneous deliveries
(n 57 098) only showed a positive association between maternal
dietary Se intake and length of gestation (Table 3).
Among all 72 025 deliveries, 3618 (5 %) women delivered
preterm, 952 (1 %) women delivered early preterm, 2666 (4 %)
late preterm, 11 660 (16%) early term and 56 747 (79 %) delivered
late term. Among the 57 098 spontaneous deliveries, 2100 (4 %)
were preterm, 482 (1 %) early preterm, 1618 (3 %) late preterm,
7873 (14 %) early term and 47 125 (82 %) late term.
Higher maternal dietary Se intake was associated with
decreased risk of PTD in all subjects (HR per SD: 0·92, 95 %
CI, 0·87, 0·98) as well as cases of spontaneous deliveries only
(HR per SD: 0·88, 95 % CI, 0·81, 0·96) (Table 4).
No associations were found between intake of inorganic
(selenite/selenate) or organic Se supplements (selenomethionine/
selenised yeast) and gestational length or PTD (Tables 3 and 4).
Analyses of intake of dietary Se and Se-containing supple-
ments in relation to the risk of early preterm, late preterm and
early term deliveries showed one significant association, that
is, Se intake from food was associated with a decreased risk of
Table 3. Association between maternal dietary selenium intake and selenium intake from supplements and gestational length*
(β-Coefficients and 95 % confidence intervals)
Unadjusted Adjusted†
β‡ 95 % CI P β‡ 95 % CI P
All subjects (n 72 025)
Se intake from food§ 0·07 −0·02, 0·17 0·13 0·25 0·07, 0·43 0·006
Se intake from inorganic supplements§ −0·04 −0·14, 0·05 0·35 −0·08 −0·17, 0·02 0·10
Se intake from organic supplements§ 0·07 −0·03, 0·16 0·17 0·07 −0·03, 0·17 0·19
Spontaneous deliveries (n 57 098)
Se intake from food§ 0·13 0·03, 0·22 0·007 0·34 0·16, 0·52 1·7 × 10−4
Se intake from inorganic supplements§ −0·08 −0·17, 0·01 0·09 −0·09 −0·18, 0·01 0·07
Se intake from organic supplements§ 0·07 −0·03, 0·16 0·17 0·07 −0·02, 0·17 0·14
Subjects with intake levels below RDI (n 41 581)‖
Se intake from inorganic supplements§ −0·12 −0·24, 0·00 0·06 −0·12 −0·23, 0·02 0·05
Se intake from organic supplements§ 0·08 −0·04, 0·21 0·19 0·10 −0·02, 0·21 0·10
Subjects with intake levels below 30 μg/d (n 1308)
Se intake from inorganic supplements§ 0·32 −0·35, 0·98 0·35 0·41 −0·25, 1·1 0·22
Se intake from organic supplements§ −0·42 −1·19, 0·35 0·28 −0·53 −1·3, 0·23 0·17
RDI, recommended daily intake.
* Multiple linear regression analysis of Se intake from food and from supplements in relation to gestational length in days for 72 025 participants in the Norwegian Mother and Child
Cohort Study. Se intake from food and supplements was assessed with an FFQ in gestational week 22.
† Adjusted for maternal age, parity, smoking habits, alcohol consumption during pregnancy, maternal education, BMI, iodine intake in five categories, fibre intake, protein intake, n-3
intake and total energy intake. Analyses for the different Se sources are also mutually adjusted in the adjusted model.
‡ β per standard deviation of Se intake. Standard deviation for Se intake from food is 14·6 μg/d, from inorganic supplements 32·6 μg/d and from organic supplements 10·0 μg/d.
§ Measured in μg/d.
‖ RDI of Se for pregnant women is 60 μg/d.
Table 4. Association between maternal dietary selenium intake and selenium intake from supplements and risk of preterm delivery*
(Hazard ratios (HR) and 95 % confidence intervals)
Unadjusted Adjusted†
HR‡ 95 % CI P HR‡ 95 % CI P
All subjects (n 72 025)
Se intake from food§ 0·97 0·94, 1·00 0·06 0·92 0·87, 0·98 0·012
Se intake from inorganic supplements§ 1·02 0·99, 1·05 0·21 1·01 0·98, 1·05 0·41
Se intake from organic supplements§ 0·99 0·95, 1·02 0·44 0·98 0·95, 1·02 0·32
Spontaneous deliveries (n 57 098)‖
Se intake from food§ 0·95 0·91, 0·99 0·02 0·88 0·81, 0·96 0·003
Se intake from inorganic supplements§ 1·05 1·01, 1·09 0·02 1·04 1·01, 1·03 0·08
Se intake from organic supplements§ 0·99 0·94, 1·04 0·64 0·98 0·93, 1·03 0·37
* Daily intake of Se from food and from supplements and HR for preterm delivery (22+0–36+6 weeks) in all subjects and in spontaneous deliveries only analysed with Cox regression.
Number of preterm deliveries: 3618 of all 72 025 subjects and 2100 of the 57 098 spontaneous deliveries. Se intake from food and supplements was assessed with an FFQ in
gestational week 22.
†Adjusted for: maternal age, parity, smoking habits, alcohol consumption during pregnancy, maternal education, BMI, iodine intake in five categories, fibre intake, n-3 intake and total
energy intake. Analyses for the different Se sources are also mutually adjusted in the adjusted model.
‡ HR per standard deviation of Se intake. Standard deviation for Se intake from food is 14·6 μg/d, from inorganic supplements 32·6 μg/d and from organic supplements 10·0 μg/d.
§ Measured in μg/d.
‖ Iatrogenic deliveries have been censored in the regression model.
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late PTD (adjusted HR per SD: 0·90, 95 % CI, 0·84, 0·97) (online
Supplementary Table S1).
Threshold analysis
Possible threshold effects of dietary Se intake were studied
by entering Se categorised into deciles into the Cox regression
models (online Supplementary Table S2). Women in four of
the seven lowest intake categories had an increased risk of
PTD compared with the reference category. No significant
association was found for higher intake categories compared
with the reference category (online Supplementary Table S2).
Maternal selenium status, gestational length and preterm
delivery
Maternal Se status at gestational week 17 was associated neither
with gestational length nor with PTD (Tables 5 and 6). The sub-
group with available whole-blood Se measurements was rela-
tively small (n 2638) and included only eighty women who
delivered preterm, fifty-five of these with spontaneous deliv-
eries, limiting the statistical power.
Discussion
Higher maternal dietary Se intake in the first half of pregnancy
was associated with increased gestational length and reduced
risk of PTD. The results were more pronounced when the
analyses were confined to women with spontaneous deliveries
only. Threshold analyses suggest that the association is driven by
Se intake below the RDI and that Se intake above the RDI does
not affect PTD risk. While a 6-h increase in gestational length
might not seem clinically relevant, this can be expected due to
the intake of a single nutrient at the population level. The corre-
sponding findings for a decreased PTD risk underline the clinical
relevance of the results. No associationswere found between the
intake of Se-containing supplements or Se status and gestational
length or risk of PTD.
Most of the dietary Se are in proteins. The bioavailability
of dietary Se depends on the digestibility of the proteins.
The protein-bound forms (selenocysteine and selenomethio-
nine) need to be converted to single amino acids and short
polypeptides that can be absorbed(37). Se in animal products
tends to be better utilised compared with Se from plant
tissues(37,38) due to the better digestibility. Fish can be an
exception(39) if it is high in heavy metals that bind Se in poorly
digestible adducts(40). Dietary supplements typically contain
Se in the form of Se -enriched brewers’ yeast or sodium
selenite or selenate. Se in yeast needs to be digested to free
Se from the yeast proteins; while the inorganic forms (sodium
selenite or selenate) can be absorbed directly. Hence, bio-
availability probably does not explain the different results
for dietary Se being associated with gestational length, while
there was no association with Se intake from supplements.
Rather, the results suggest that most of the women in the
Table 5. Association between maternal selenium blood concentration in mid-pregnancy and gestational length*
(β-Coefficients and 95 % confidence intervals)
Unadjusted Adjusted†
β‡ 95% CI P β‡ 95% CI P
All subjects (n 2638)
Blood Se concentration§ 0·12 −0·27, 0·50 0·55 −0·02 −0·41, 0·38 0·94
Spontaneous deliveries (n 2177)
Blood Se concentration§ 0·10 −0·28, 0·49 0·60 0·03 −0·36, 0·42 0·89
* Multiple linear regression analysis of blood Se concentrations in relation to gestational length in days for 2638 participants in the Norwegian
Mother and Child Cohort Study. Blood Se concentration was measured in whole blood collected in gestational week 17−18 in a subsample of
2638 of the 72 025 participating mothers.
† Adjusted for: maternal age, parity, smoking habits, alcohol consumption during pregnancy, maternal education and BMI.
‡ β per standard deviation (23·4 μg/l) of blood Se concentration.
§ Measured in μg/l.
Table 6. Association between maternal selenium blood concentration in mid-pregnancy and risk of preterm delivery*
(Hazard ratios (HR) and 95 % confidence intervals)
Unadjusted Adjusted†
HR‡ 95 % CI P HR‡ 95% CI P
All subjects (n 2638)
Blood Se concentration§ 0·91 0·72, 1·15 0·42 0·93 0·74, 1·18 0·93
Spontaneous deliveries (n 2177)‖
Blood Se concentration§ 0·91 0·69, 1·21 0·52 0·92 0·69, 1·22 0·56
* Maternal blood Se concentrations (μg/l) and HR for preterm delivery (22+0–36+6 weeks) in all subjects with Se bloodmeasurements (n 2638) and
in spontaneous deliveries only (n 2177) analysed with Cox regression. Number of preterm cases: 80 of all 2638 subjects and 55 of the 2177
spontaneous deliveries. Blood Se concentrations were measured in whole blood collected in gestational week 17–18.
† Adjusted for maternal age, parity, smoking habits, alcohol consumption during pregnancy, maternal education and BMI.
‡ HR per standard deviation (23·4 μg/l) of blood Se concentrations.
§ Measured in μg/l.
‖ Iatrogenic deliveries have been censored in the regression model.
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cohort have dietary Se intake near or above the level associ-
ated with optimal selenoprotein expression, especially the
third of women who also consumed Se-containing supple-
ments who are more likely to have Se intake from food more
than the RDI. Thus, intake of Se-containing supplements
would not further improve selenoprotein expression affecting
metabolic pathways related to birth outcome, for example,
inflammation or redox status.
Se in whole blood circulates either bound to plasma-
selenoproteins glutathione peroxidase 3 and selenprotein 1 or
in the form of glutathione peroxidase 1 in the erythrocytes
and lymphocytes. Also other proteins that contain Se non-
specifically incorporated in lieu of methionine are found in
both compartments. The relative expression level of these
three selenoproteins is thought to reflect the expression of other
selenoproteins in the body. The expression of selenoproteins is
dependent not only on dietary Se intake but also on genetic
variation in genes involved in the Se metabolism such as
dimethylglycine dehydrogenase(41), selenoprotein P(42), the
glutathione peroxidases, cytosolic glutathione peroxidase
and phospholipid glutathione peroxidase(43). Based on the
findings from our recent genome-wide association study,
where we reported genome-wide significance for one of
the genes involved in the Se metabolism, the EEFSEC gene,
we hypothesised that Se intake and/or Se status during preg-
nancy would be correlated with gestational length and PTD.
The epidemiological findings in the present study, that dietary
Se intake in the first half of pregnancy was associated with
increased gestational length and reduced risk of PTD, further
support this hypothesis. As a next step, we plan to perform
gene–environment interaction analyses to gain further knowl-
edge in how Se influences the length of gestation and the risk
of PTD and to examine whether EEFSEC polymorphisms
interfere with the association between dietary Se intake and
whole blood Se concentrations.
Only a few other studies evaluated Se intake in relation to
gestational length and/or PTD. One small nested case–control
study in New Jersey, USA, including 107 women who deliv-
ered preterm and 126 control women, used a 24-h recall
dietary assessment to estimate Se intake at entry to prenatal
care. The results showed that women who delivered preterm
had a higher Se intake in the first trimester compared with
controls (115 (9) v. 93 (5) μg/d, P < 0·03)(14), hence opposite
results to what was found in the present study. However, the
New Jersey study compared only 107 cases with 126 controls,
while the present study compared 3618 cases with 68 407 con-
trols. Further, the FFQ used in the MoBa cohort has been
extensively validated(18,19). A larger multicentre study in the
USA, including 5738 deliveries (471 PTD cases) from the
National Birth Defects Prevention Study found no association
between Se intake and PTD. Se intake during the year before
pregnancy was estimated retrospectively by telephone inter-
view 6–24 months after delivery using a short FFQ of 58 food
items, impairing the validity of the results(13). For the MoBa
cohort, dietary data were collected prospectively with an
extensively validated instrument in a more than 10 times as
large study population. The USA study reported a higher
intake compared with that reported in Norway in the MoBa
cohort(13).
For 2638 of the 75 025 women included in the present study,
Se status measured in gestational weeks 17–18 was available. No
associations were found between Se status and either of the
outcomes, gestational length and PTD. We are not aware of
other studies that evaluated Se in whole blood in the first
half of pregnancy in relation to gestational length and PTD.
However, in accordance with the present findings, Bogden
et al.(14) observed no differences in plasma Se concentration
at gestational week 15 for women who delivered preterm
(n 107) compared with those who delivered at term (n 126)
(1·37 (0·02) v. 1·34 (0·02) μmol/l). On the other hand,
Rayman et al.(15) found that women in the Netherlands who
delivered preterm (n 60) had lower serum Se concentration
at gestational week 12 than those who delivered at term
(0·96 (0·14) v. 1·02 (0·13) μmol/l, P = 0·001). We have
reported Se concentration in whole blood in μg while
Rayman et al. and Bogden et al. reported the Se concentra-
tions in serum in μmol. The median Se of 102 μg/l in whole
blood found in our study population corresponds to
1·3 μmolar/l, which is comparable with the concentration
measured in serum and plasma in the other studies.
Se from diet and supplements containing organic Se (seleno-
methionine or selenised yeast) was weakly correlated with
Se concentration in blood, while no association was found
for inorganic Se. Selenomethionine, the dominant form in
foods, is incorporated specifically into selenoproteins as well
as non-specifically into other proteins, for example, albumin.
It is likely that women consuming less than 60 μg of the RDI
had suboptimal expression of selenoenzymes, and they
would be expected to show increased selenoprotein expres-
sion in response to all absorbable forms of Se.
Fig. 2. Contribution (%) to dietary selenium intake by different food sources. ,
Seafood; , bread; , meat, all types; , pasta; , dairy products; , fruit
and vegetables; , eggs; , cheese; , rice, millet, couscous; , waffles,
pancakes; , pizza, tacos; , cereals; , snacks and candy; , biscuits
and cookies; , nuts; , rice porridge.
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An interesting aspect of our findings is that blood Se concen-
trations in Norwegians have dropped quite dramatically in the
last 30 years, from being among the highest in Europe, on aver-
age approximately 150 μg/l(44) whole blood (corresponding to
120 μg/l serum/plasma) to approximately 100 μg/l in the present
study. This has brought Norwegians down to similar blood Se
concentration as found among Swedes and Danes. This change
may relate to decreasing consumption of trans-Atlantic flour
from Se-rich areas in Canada and the USA, in favour of increased
use of North-European grains, which are typically of lower Se
content. The finding in the present study that supplementary
Se had little influence on the blood concentration might be
due to the fact that the third of women who chose to consume
Se-containing supplements were those who were more likely to
meet the RDI by their dietary Se intake.
Strengths and limitations
This is by far the largest study investigating the association
between Se intake and gestational length and PTD. The prospec-
tive design and the detailed information about maternal diet,
demography, socioeconomic factors and pregnancy outcomes
are further strengths. The study is population based, including
women from all over Norway, representing women living in
urban and rural areas, coastland and inland regions, different
socioeconomic groups and women with diverse dietary habits.
Due to the large sample size, even subgroups of PTD could be
studied.
Observational studies cannot establish causality as there is
always a risk of residual confounding.However, the comprehen-
sive data set allowed us to account for a large number of possible
confounders, including maternal age and education, parity,
smoking and energy intake.
The dietary intake was estimated before delivery using an
FFQ specifically developed and validated for use in this
cohort(17,19). Se intake estimated using this instrument was sig-
nificantly correlated with Se intake estimated using a 4-d food
diary in the validation study (r 0·28 for Se in food)(19).
However, the use of an FFQ has limitations and is more suitable
for ranking participants according to high and low intake than for
precise intake calculations. Since the Se content varies according
to the Se concentration of the soil where crops are grown or the




























Fig. 3. Distribution of dietary selenium intake and selenium intake from supplements (organic and inorganic forms combined). Histograms showing the intake of
selenium from food (a) and from supplements (b). Only supplement users (n 23 409) are included in (b). RDI, recommended daily intake. For pregnant women, the
RDI for selenium is 60 μg/d.
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animals graze, some uncertainty is associated with estimating Se
intake from food composition databases. When testing whether
the Se content in blood varied depending on the year of inclu-
sion into MoBa, significant differences were found, with concen-
trations ranging from a median of 87 to 114 μg/l between years
2003 and 2009 (results not shown). Women in the present study
reported the intake of food and dietary supplements. Food habits
are often stable over time, while intake of supplements fluctuate,
especially during such a sensitive period as pregnancy, sug-
gesting that the long-term intake of Se, and hence storage of
Se in the body, is better captured in the questions about food
than about supplement use.
Participants in MoBa were recruited between 10 and 20 years
ago and dietary trends change over time. Thismay limit the trans-
lation of the findings. However, Se is found in many different
food items and most of them are staple foods such as wheat,
meat and fish.We have little reason to believe thatmajor changes
were observed in the intake pattern of Se-rich food items during
the past decade, though the dishes they are part of may have
changed.
The generalisability of the results from the Semeasurements in
whole bloodmay be limited due to selection bias. Since one inclu-
sion criterion for participation in the Norwegian Environmental
Biobank Studywas tohave answered all of the first sixMoBaques-
tionnaires, the subgroup of women who have Se measurements
do not represent the whole MoBa population(27). Women in the
subsample included a lower proportion with missing information
on baseline characteristics and a higher proportion of non-
smokers and highly educated compared with those in the whole
MoBa(27).
Conclusions
Higher Se intake from food but not from supplements was asso-
ciated with a small increase in gestational length and decreased
risk of PTD in 72 075 women participating in MoBa, strengthen-
ing the results from the first genome-wide association study on
gestational length and PTD(4). The reason for the different find-
ings for Se in different sources, that is, from supplements and
from food, may be due to the fact that about half of the women
had a dietary Se intake more than the RDI, which is thought to
guarantee an optimal selenoenzyme expression. Further studies,
preferably in the form of randomised controlled trials and gene–
environment interaction analyses, are needed before consider-
ing to change the present dietary guidelines regarding Se intake
by pregnant women.
Acknowledgements
The Norwegian Mother, Father and Child Cohort Study is sup-
ported by the Norwegian Ministry of Health and Care Services
and the Ministry of Education and Research. We are grateful
to all the participating families in Norway, who take part in this
on-going cohort study.
The Norwegian Mother, Father and Child Cohort Study is
supported by the Norwegian Ministry of Health and Care
Services and the Ministry of Education and Research,
NIH/NINDS (grant no. 1 UO1 NS 047537-01 and grant no. 2
UO1 NS 047537-06A1). Payment for access to data and
article-processing charges for this publication was covered
by grants from the Wilhelm and Martina Lundgren
Foundation (grant no. 2017-1788 to M. B.) and The Royal
Society of Arts and Sciences in Gothenburg (grant no. 2017-
054 to M. B.). The Bill & Melinda Gates Foundation provided
grant no. OPP1175128 to L. J. M. Agreement concerning
research and education of doctors (ALFGBG-717501),
Sahlgrenska University Hospital, Sahlgrenska Academy,
Gothenburg, Sweden, to B. J. March of Dimes (no. 21-FY16-
121) to B. J. The Health & Medical Care Committee of the
Regional Executive Board, Region Västra Götaland, Sweden
(VGFOUREG-658361) to B. J.
All co-authors have contributed significantly to the plan-
ning of the analyses and interpretation of the data and have
provided essential intellectual input. M. B., S. N. and V. S.
did the statistical analyses. M. B. wrote the first draft of the
manuscript. All authors approved the final version of the
manuscript. The principal investigator, V. S., had full access
to the data and had final responsibility for the decision to sub-
mit for publication.
The authors declare no conflicts of interest regarding the con-
tent of this paper.
Supplementary material
For supplementary material/s referred to in this article, please
visit https://doi.org/10.1017/S0007114519002113
References
1. Morken NH, Vogel I, Kallen K, et al. (2008) Reference popula-
tion for international comparisons and time trend surveillance
of preterm delivery proportions in three countries. BMC
Womens Health 8, 16.
2. Ferrero DM, Larson J, Jacobsson B, et al. (2016) Cross-country
individual participant analysis of 4.1 million singleton births in
5 countries with very high human development index confirms
known associations but provides no biologic explanation
for 2/3 of all preterm births. PLOS ONE 11, e0162506.
3. Chang HH, Larson J, Blencowe H, et al. (2013) Preventing pre-
term births: analysis of trends and potential reductions with
interventions in 39 countries with very high human develop-
ment index. Lancet 381, 223–234.
4. Zhang G, Feenstra B, Bacelis J, et al. (2017) Genetic associa-
tions with gestational duration and spontaneous preterm birth.
N Engl J Med 377, 1156–1167.
5. Labunskyy VM, Hatfield DL & Gladyshev VN (2014)
Selenoproteins: molecular pathways and physiological roles.
Physiol Rev 94, 739–777.
6. Mullur R, Liu Y-Y & Brent GA (2014) Thyroid hormone regula-
tion of metabolism. Physiol Rev 94, 355–382.
7. BurnumKE, Hirota Y, Baker ES, et al. (2012) Uterine deletion of
Trp53 compromises antioxidant responses in the mouse
decidua. Endocrinology 153, 4568–4579.
8. Goldenberg RL, Culhane JF, Iams JD, et al. (2008) Epidemiology
and causes of preterm birth. Lancet 371, 75–84.
9. Muglia LJ & Katz M (2010) The enigma of spontaneous preterm
birth. N Engl J Med 362, 529–535.
218 M. Barman et al.
10. Chen C-Y, Chen C-P & Lin K-H (2015) Biological functions of
thyroid hormone in placenta. Int J Mol Sci 16, 4161–4179.
11. World Health Organization (2012) Born Too Soon: The Global
Action Report on Preterm Birth. Geneva: WHO.
12. Hurst R, Siyame EW, Young SD, et al. (2013) Soil-type
influences human selenium status and underlies widespread
selenium deficiency risks in Malawi. Sci Rep 3, 1425.
13. Carmichael SL, YangW, ShawGM, et al. (2013)Maternal dietary
nutrient intake and risk of preterm delivery. Am J Perinat 30,
579–588.
14. Bogden JD, Kemp FW, Chen X, et al. (2006) Low-normal serum
selenium early in human pregnancy predicts lower birth
weight. Nutr Res 26, 497–502.
15. Rayman MP, Wijnen H, Vader H, et al. (2011) Maternal
selenium status during early gestation and risk for preterm birth.
CMAJ 183, 549–555.
16. Magnus P, Birke C, VejrupK, et al. (2016) Cohort profile update:
the Norwegian mother and child cohort study (MoBa). Int J
Epidemiol 45, 382–388.
17. Meltzer HM, Brantsaeter AL, Ydersbond TA, et al. (2008)
Methodological challenges when monitoring the diet of preg-
nant women in a large study: experiences from the
Norwegian Mother and Child Cohort Study (MoBa). Matern
Child Nutr 4, 14–27.
18. Brantsaeter AL, Haugen M, Thomassen Y, et al. (2010)
Exploration of biomarkers for total fish intake in pregnant
Norwegian women. Public Health Nutr 13, 54–62.
19. Brantsaeter AL, Haugen M, Alexander J, et al. (2008) Validity of
a new food frequency questionnaire for pregnant women in the
Norwegian Mother and Child Cohort Study (MoBa). Matern
Child Nutr 4, 28–43.
20. Lauritsen J (1998) FoodCalc v. 1.3: Diet, Cancer and Health
Project. Copenhagen: Danish Cancer Society.
21. Rimestad A, Borgejordet Å, Vesterhus K, et al. (2005) Den store
matvaretabellen (The Norwegian Food Table). Oslo: Statens råd
for ernæring og fysisk aktivitet, Statens næringsmiddeltilsyn,
Universitetet i Oslo ‐ Institutt for ernæringsforskning.
22. Haugen M, Brantsaeter AL, Alexander J, et al. (2008) Dietary
supplements contribute substantially to the total nutrient
intake in pregnant Norwegian women. Ann Nutr Metab 52,
272–280.
23. Brantsaeter AL, Haugen M, Hagve TA, et al. (2007) Self-
reported dietary supplement use is confirmed by biological
markers in the Norwegian Mother and Child Cohort Study
(MoBa). Ann Nutr Metab 51, 146–154.
24. Niedzielski P, Rudnicka M, Wachelka M, et al. (2016) Selenium
species in selenium fortified dietary supplements. Food Chem
190, 454–459.
25. Sigrist M, Brusa L, Campagnoli D, et al. (2012) Determination of
selenium in selected food samples from Argentina and estima-
tion of their contribution to the Se dietary intake. Food Chem
134, 1932–1937.
26. Paltiel L, Haugan A, Skjerden T, et al. (2014) The biobank of the
Norwegian mother and child cohort study – Present status.
Norsk Epidemiol 24, 29–35.
27. Caspersen IH, Thomsen C, Haug LS, et al. (2019) Patterns and
dietary determinants of essential and toxic elements in blood
measured in mid-pregnancy: the Norwegian Environmental
Biobank. Sci Total Environ 671, 299–308.
28. Ronningen KS, Paltiel L, Meltzer HM, et al. (2006) The biobank
of the NorwegianMother and Child Cohort Study: a resource for
the next 100 years. Eur J Epidemiol 21, 619–625.
29. Paltiel L, Anita H, Skjerden T, et al. (2014) The biobank of the
Norwegian Mother and Child Cohort Study – present status.
Norsk Epidemiol 24, 29–35.
30. Thomson CD (2004) Assessment of requirements for selenium
and adequacy of selenium status: a review. Eur J Clin Nutr 58,
391–402.
31. Englund-Ögge L, Brantsæter AL, Sengpiel V, et al. (2014)
Maternal dietary patterns and preterm delivery: results from
large prospective cohort study. BMJ 348, g1446.
32. Abel MH, Korevaar T, Erlund I, et al. (2018) Iodine intake is
associated with thyroid function in mild- to moderately iodine
deficient pregnant women. Thyroid 28, 1359–1371.
33. Abel MH, Ystrom EA-O, Caspersen IA-O, et al. (2017) Maternal
iodine intake and offspring attention-deficit/hyperactivity
disorder: results from a large prospective cohort study.
Nutrients 9, 1239.
34. Charoenratana C, Leelapat P, Traisrisilp K, et al. (2016)Maternal
iodine insufficiency and adverse pregnancy outcomes. Matern
Child Nutr 12, 680–687.
35. Middleton P, Gomersall JC, Gould JF, et al. (2018) Omega-3
fatty acid addition during pregnancy. Cochrane Database
Syst Rev, issue 11, CD003402.
36. Vinding RK, Stokholm J, Sevelsted A, et al. (2019) Fish oil sup-
plementation in pregnancy increases gestational age, size for
gestational age, and birth weight in infants: a randomized con-
trolled trial. J Nutr 149, 628–634.
37. Combs GF & Combs SB (1986) The biological availability of
selenium in foods and feeds. In The Role of Selenium in
Nutrition, chapter 4, pp. 127–177 [GF Combs and SB Combs,
editors]. Cambridge, MA: Academic Press.
38. Cantor AH, Moorhead PD &Musser MA (1981) Biological avail-
ability of selenium in selenium compounds and feed ingre-
dients. In Selenium in Biology and Medicine, chapter 17, pp.
192–208 [JE Spallholz, JL Martin and HE Ganther, editors].
Westport, CT: AVI Publishing Co.
39. Cantor AH, Scott ML & Noguchi T (1975) Biological availability
of selenium in feedstuffs and selenium compounds for preven-
tion of exudative diathesis in chicks. J Nutr 105, 96–105.
40. Shamberger R (2012) Biological interactions of selenium and
other substances. In Biochemistry of Selenium, pp. 125–166.
New York: Springer US, Plenum Press.
41. Evans DM, ZhuG, Dy V, et al. (2013) Genome-wide association
study identifies loci affecting blood copper, selenium and zinc.
Hum Mol Genet 22, 3998–4006.
42. Meplan C, Crosley LK, Nicol F, et al. (2007) Genetic polymor-
phisms in the human selenoprotein P gene determine the
response of selenoprotein markers to selenium supplementa-
tion in a gender-specific manner (the SELGEN study). FASEB
J 21, 3063–3074.
43. Meplan C, Crosley LK, Nicol F, et al. (2008) Functional effects of
a common single-nucleotide polymorphism (GPX4c718t) in the
glutathione peroxidase 4 gene: interaction with sex. Am J Clin
Nutr 87, 1019–1027.
44. Meltzer HM, Norheim G, Bibow K, et al. (1990) The form of
selenium determines the response to supplementation in a
selenium replete population. Eur J Clin Nutr 44, 435–446.
Selenium in pregnancy and preterm delivery 219
